Ehlers–Danlos Syndrome: Understanding a Complex Connective Tissue Disorder. By: Ayomide Makinde
Introduction.
Ehlers-Danlos syndromes (EDS) are a group of 13 inherited connective
tissue disorders caused by genetic changes that affect the body's
connective tissues, which provide support and strength to the skin,
joints, blood vessels, and internal organs. Each type of EDS has its own
distinct set of characteristics and diagnostic criteria. However, many
people with EDS experience common features such as joint
hypermobility (unusually flexible joints), skin hyperextensibility (skin
that stretches more than usual), and tissue fragility. EDS is estimated to
affect approximately one in every 5,000 people worldwide and can occur
in individuals of any sex, race, or ethnic background.
Main Body
EDS is caused by genetic changes that affect connective tissue - It is
especially caused by a faulty gene that causes your body to produce not
enough collagen. Since the function of collagen is to maintain support
across the connective tissues in your body, having the condition can
result in overly flexible joints and fragile skin. There are 13 recognised
types of Ehlers-Danlos syndromes (EDS) and they are as follows -
● Arthrochalasia EDS (aEDS)
● Brittle cornea syndrome (BCS)
● Cardiac valvular EDS (cvEDS)
● Classical EDS (cEDS)
● Classical-like EDS (clEDS)
● Dermatosparaxis (dEDS)
● Hypermobile EDS (hEDS)
● Kyphoscoliotic EDS (kEDS)
● Musculocontractural EDS (mcEDS)
● Myopathic EDS (mEDS)
● Periodontal EDS (pEDS)
● Spondylodysplastic EDS (spEDS)
● Vascular EDS (vEDS)
Symptoms
Diagnosis
For many individuals with Ehlers-Danlos syndrome (EDS), obtaining a
diagnosis is often a lengthy and challenging process. Limited awareness
of the condition among healthcare professionals means that the signs
and symptoms are frequently overlooked or misinterpreted. As a result,
many people are initially diagnosed with other conditions, such as
fibromyalgia, myalgic encephalomyelitis/chronic fatigue syndrome
(ME/CFS), or irritable bowel syndrome (IBS), depending on the
symptoms they present. It is not uncommon for individuals to wait
many years, or even decades, before receiving an accurate diagnosis,
and some may never be diagnosed at all. However, receiving a correct
diagnosis is essential, as it enables appropriate management, access to
specialist care, and a better understanding of the condition.
Common Treatments for EDS
● Physiotherapy - The main treatment for most people with EDS.
Physiotherapy helps strengthen muscles, improve joint stability,
reduce pain, and lower the risk of joint dislocations.
● Pain management -Pain can be managed with medications such
as paracetamol, non-steroidal anti-inflammatory drugs (NSAIDs),
or, in some cases, stronger prescription medications under
medical supervision. Referral to a specialist pain clinic may also be
beneficial.
● Occupational therapy - Occupational therapists provide advice on
joint protection, energy conservation (pacing), adaptive
equipment, and strategies to make daily activities easier.
● Exercise -Low impact activities such as swimming, cycling, and
Pilates can improve muscle strength and cardiovascular fitness
while minimising stress on the joints. High-impact sports and
contact sports are generally discouraged.
● Surgery - Surgery is usually considered only when absolutely
necessary because fragile connective tissue can make healing
more difficult and increase the risk of complications.
● Lifestyle modifications - Pacing activities, maintaining a healthy
weight, avoiding excessive strain on joints, and learning
self-management techniques can help reduce symptoms and
improve day to day functioning
Why Awareness Matters
Awareness of Ehlers-Danlos syndromes is essential because it can lead
to earlier diagnosis, reduce the risk of misdiagnosis, and ensure that
individuals receive appropriate treatment and specialist care. Greater
understanding among healthcare professionals and the public can
improve patients' quality of life, help prevent complications, and provide
access to the support they need. In addition, raising awareness
promotes research into EDS, increasing the likelihood of improved
treatments and better outcomes for those living with these lifelong
connective tissue disorders.
Conclusion.
As research continues to advance our understanding of the genetic and
biological mechanisms underlying EDS, there is hope that new
therapies and improved standards of care will become available. Until
then, education, awareness, and continued support remain vital in
ensuring that people with Ehlers-Danlos syndromes receive the
recognition, care, and understanding they deserve.
References.
The Ehlers-Danlos Society. (2017). What is EDS? The Ehlers Danlos
Society. https://www.ehlers-danlos.com/what-is-eds/
Ehlers-Danlos Syndrome (EDS). (2025). Childrenshospital.Org.
https://www.childrenshospital.org/conditions-treatments/ehlers-danlos
-syndrome
Harrod, A. (2022, May 5). The Importance of Raising Awareness for EDS and
HSD within Society. Bursting With Potential.
https://burstingwithpotential.co.uk/the-importance-of-raising-awarene
ss-for-eds-and-hsd-within-society/
Livi. (2022, September 16). Livi.
https://www.livi.co.uk/medical-advice/musculoskeletal/ehlers-danlos-sy
ndrome/
The Ehlers-Danlos Support UK. (2021). The Ehlers-Danlos Support UK.
https://www.ehlers-danlos.org/what-is-eds/information-on-eds/diagno
sis
Ehlers Danlos Syndrome (EDS). (2026). East Genomics.
https://www.eastgenomics.nhs.uk/for-healthcare-professionals/clinical
-genetics-services/east-anglian-medical-genetics-service/referrals/refe
rrals-not-routinely-accepted/ehlers-danlos-syndrome-eds/
Orthopedic Management of the Ehlers-Danlos Syndromes (for Non-experts)
- The Ehlers Danlos Society. (2022, March 14). The Ehlers Danlos Society.
https://www.ehlers-danlos.com/2017-eds-classification-non-experts/or
thopedic-management-ehlers-danlos-syndrome
Ehlers-Danlos Syndrome. (2024). Medlineplus; National Library of
Medicine.
https://medlineplus.gov/ehlersdanlossyndrome.html?utm_source=es/
Comments
Post a Comment